Advertisement
News
Subscribe to MDT Magazine News

Roche Receives FDA Clearance for U.S. Launch of cobas 8000 Modular Analyzer Series for High-Volume Laboratory Testing

September 13, 2010 10:34 am | by Bio-Medicine.Org | Comments

INDIANAPOLIS, Sept. 13 /- Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas® 8000 modular analyzer series, a Serum Work Area solution designed for diagnostic laboratories with...

TOPICS:

SentiCare moves into medication testing programs

September 13, 2010 8:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Southborough-based SentiCare Inc. has received an unspecified amount of funds to conduct institutional review board protocol trials involving its PillStation medical adherance system.

Allied Telesis, Hosted PACS Solutions Join Forces to Deliver Managed Cloud-Based Picture Archiving and Communications Systems (PACS) Services

September 13, 2010 8:33 am | by Bio-Medicine.Org | Comments

SAN JOSE, Calif. and WELLINGTON, Fla., Sept. 13 /- Allied Telesis Inc ., a global provider of secure IP/Ethernet switching solutions and an industry leader in the deployment of converged multi-play networks, and Hosted PACS Solutions , an application service provider (ASP) of...

TOPICS:
Advertisement

Regeneron Announces Presentation at the UBS Global Life Sciences Conference

September 13, 2010 8:33 am | by Bio-Medicine.Org | Comments

TARRYTOWN, N.Y., Sept. 13 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) will webcast its presentation at the UBS Global Life Sciences Conference on Monday, September 20, 2010.  The presentation is scheduled for 10:00 a.m. Eastern Time.  The session may be accessed through...

TOPICS:

New Insights Provide Promise for Development of Tools to Protect Damaged Tissues

September 13, 2010 8:33 am | by Bio-Medicine.Org | Comments

MEMPHIS, Tenn., Sept. 13 /PRNewswire-USNewswire/ -- St. Jude Children's Research Hospital investigators have identified a novel structure in cells that serves as a control switch in the body's system for eliminating damaged cells and also offers new therapeutic potential. The findings...

TOPICS:

North American Spine Welcomes Kenneth Alo, M.D. to Physician Group

September 13, 2010 8:32 am | by Bio-Medicine.Org | Comments

HOUSTON, Sept. 13 /- North American Spine is pleased to announce that Kenneth Alo, M.D. has joined to help further the advancement of minimally invasive pain treatment techniques used to both diagnose and treat inter-vertebral lumbar discs, spinal stenosis and many other causes of back...

TOPICS:

Genzyme genetic testing unit nets $925M buyout

September 13, 2010 6:31 am | by Mass High Tech: The Journal of New England Technology | Comments

Genzyme Corp. is selling its genetic testing business for $925 million in cash to Laboratory Corporation of America Holdings, which plans to offer jobs to Genzyme Genetics’ 1,900 employees.

MarketsandMarkets: Magnetic Resonance Imaging (MRI) Global Market Worth US$ 5,844.4 Million By 2015

September 13, 2010 6:31 am | by Bio-Medicine.Org | Comments

MarketsandMarkets: Magnetic Resonance Imaging (MRI) Global Market Worth US$ 5,844.4 Million By 2015 -- DALLAS, September 13, 2010 /-

TOPICS:
Advertisement

Siemens and National Semiconductor Align to Advance Ultrasound Technology

September 13, 2010 5:37 am | Comments

Siemens Medical Solutions USA, Inc. and National Semiconductor Corporation announce a wide-ranging strategic alliance to advance ultrasound technology, creating ultrasound imaging systems...

TOPICS:

Leading Dutch Cancer Center Commences Treatments Using New TrueBeam from Varian Medical Systems

September 13, 2010 4:33 am | by Bio-Medicine.Org | Comments

AMSTERDAM, Sept. 13 /- An 80-year-old lung cancer patient has become the first person in The Netherlands to be treated using a new linear accelerator that can deliver precise radiotherapy more quickly than conventional systems. VU University Medical Center carried out the treatment last...

TOPICS:

Genoptix Announces Participation at the 2010 UBS Global Life Sciences Conference

September 13, 2010 4:32 am | by Bio-Medicine.Org | Comments

CARLSBAD, Calif., Sept. 13 /- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the Company's participation at the 2010 UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York City, to be held September 20-22, 2010.  ...

TOPICS:

AultCare/Cardiocom® White Paper Shows Telehealth Services Reduce ER Visits and Inpatient Stays for Patients

September 13, 2010 4:32 am | by Bio-Medicine.Org | Comments

CANTON, Ohio, Sept. 13 /- AultCare has been using patient telemonitoring for six years and has, in partnership with Cardiocom, released a white paper entitled, "AultCare Sees Positive Results from Cardiocom Program." The paper describes the structure of the coordinated program between...

TOPICS:

Debiopharm Group™ and Aurigene Nominate Development Candidate

September 13, 2010 12:33 am | by Bio-Medicine.Org | Comments

LAUSANNE, Switzerland, and BANGALORE, India, Sept. 13 /- Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies...

TOPICS:

CareFusion Launches Spinal Treatment Device

September 12, 2010 11:31 pm | by San Diego Business Journal | Comments

CareFusion Corp., a medical technology company based in San Diego, has launched the AVAmax Vertebral Balloon, a device designed to improve and reduce the costs of kyphoplasty, a treatment for spinal compression fractures.

TOPICS:

Cancer deaths fall, but prevention still lags behind

September 12, 2010 10:34 pm | by EurekAlert | Comments

(ECCO-the European CanCer Organisation) Although overall mortality from cancer is decreasing in the European Union, its incidence increased by almost 20 percent, from 2.1 million new cases in 2002 to 2.5 million in 2008, says a special issue of the European Journal of Cancer (the...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading